Stay updated with breaking news from Genprex Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genprex, Inc. (NASDAQ:GNPX – Get Free Report) shares rose 1% on Wednesday . The company traded as high as $3.00 and last traded at $2.91. Approximately 119,449 shares traded hands during trading, an increase of 18% from the average daily volume of 101,125 shares. The stock had previously closed at $2.88. Analysts Set New Price […]
Viral Vector Market was worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 billion USD by 2029.
HC Wainwright reiterated their buy rating on shares of Genprex (NASDAQ:GNPX – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $10.00 price objective on the stock. Genprex Trading Up 0.8 % Shares of NASDAQ:GNPX traded up $0.02 on Wednesday, hitting $2.53. 38,029 shares of the company were exchanged, […]
HC Wainwright reaffirmed their buy rating on shares of Genprex (NASDAQ:GNPX – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. Genprex Stock Up 0.8 % Genprex stock traded up $0.02 during mid-day trading on Wednesday, hitting $2.53. 38,029 […]
Genprex, Inc. (NASDAQ:GNPX – Free Report) – HC Wainwright boosted their Q1 2024 earnings per share estimates for Genprex in a note issued to investors on Wednesday, April 3rd. HC Wainwright analyst Y. Chen now expects that the company will earn ($2.54) per share for the quarter, up from their previous estimate of ($3.37). HC […]